================================================================================
PHARMACY SALES PRESCRIPTIVE RECOMMENDATIONS (IMPROVED)
Generated: 2025-10-23 15:34:52
================================================================================

üì¶ INVENTORY MANAGEMENT RECOMMENDATIONS:

  ‚úì HIGH PRIORITY REORDERS (Top 5 by demand):
    ‚Ä¢ RETASAR (LOSARTAN POTASSIUM) 50MG: Reorder at 393 units
      - Safety stock: 201 units | 30-day forecast: 728 units
    ‚Ä¢ NOVASARTAN (LOSARTAN K) 50MG FC TAB: Reorder at 373 units
      - Safety stock: 192 units | 30-day forecast: 588 units
    ‚Ä¢ OHHIRA&#039;S RED OMX PROBIOTICS CAP: Reorder at 166 units
      - Safety stock: 71 units | 30-day forecast: 248 units
    ‚Ä¢ BIOGESIC (PARACETAMOL) 500MG TAB: Reorder at 169 units
      - Safety stock: 99 units | 30-day forecast: 152 units
    ‚Ä¢ APPEVIT (BUCLIZINE HCL+B-COMPLEX+IRON) CAP: Reorder at 146 units
      - Safety stock: 77 units | 30-day forecast: 332 units

üìã ORDERING STRATEGY RECOMMENDATIONS:

  ‚úì OPTIMAL ORDER QUANTITIES (Top 5):
    ‚Ä¢ RETASAR (LOSARTAN POTASSIUM) 50MG: Order 2365 units every 77 days
    ‚Ä¢ BIOGESIC (PARACETAMOL) 500MG TAB: Order 1747 units every 60 days
    ‚Ä¢ APPEVIT (BUCLIZINE HCL+B-COMPLEX+IRON) CAP: Order 799 units every 38 days
    ‚Ä¢ NOVASARTAN (LOSARTAN K) 50MG FC TAB: Order 1919 units every 97 days
    ‚Ä¢ OHHIRA&#039;S RED OMX PROBIOTICS CAP: Order 407 units every 22 days

üí∞ BUDGET ALLOCATION RECOMMENDATIONS:

  ‚úì PRIORITIZE INVESTMENT IN:
    ‚Ä¢ RETANIX (CETIRIZINE) 10MG TAB: 350364 units ($852,432.41)

üíµ PRICING & DISCOUNT RECOMMENDATIONS:

  ‚úì MAINTAIN/INCREASE DISCOUNTS FOR:
    ‚Ä¢ BETTER C (ASCORBIC ACID ) 500MG TAB: 0.0% discount (efficiency: 9500.0)
    ‚Ä¢ MULTICAPS: 0.0% discount (efficiency: 7575.0)
    ‚Ä¢ LIVERAIDE (SILYMARIN) CAP: 0.0% discount (efficiency: 971.4)

üìà SALES GROWTH OPPORTUNITIES:

  ‚úì PROMOTE HIGH-MARGIN PRODUCTS:
    ‚Ä¢ #EXP2025-03-30: 100.0% margin
    ‚Ä¢ #EXP2025-03-31: 100.0% margin
    ‚Ä¢ #EXP2026-07-30: 100.0% margin
    ‚Ä¢ #EXP2027-05-24: 100.0% margin
    ‚Ä¢ ALCIFLORA (BACILLUS CLAUSII) 5ML: 100.0% margin

‚öôÔ∏è OPERATIONAL EFFICIENCY:

  ‚úì INVESTIGATE 100 ANOMALOUS SALES DAYS
    ‚Ä¢ 2024-09-18: $118,645.44 (Score: -0.79)
    ‚Ä¢ 2024-03-21: $66,970.49 (Score: -0.75)
    ‚Ä¢ 2024-03-18: $87,535.88 (Score: -0.72)

üèóÔ∏è RESOURCE PLANNING (Next 90 Days):

  ‚úì PREPARE FOR NEXT QUARTER:
    ‚Ä¢ Storage needed: 71,597 cubic feet
    ‚Ä¢ Capital required: $1,054,039.07